Prostate cancer is the most common cancer in male veterans. Under 38 CFR § 4.115b, Diagnostic Code 7528 (Malignant Neoplasms of the Genitourinary System), the VA rates active prostate cancer at 100% during treatment — and for six months after treatment ends. But the real strategic question isn't the 100% treatment rating. It's what happens after treatment: secondary conditions from prostate cancer treatment — erectile dysfunction, urinary incontinence, bowel dysfunction — can be rated separately and often maintain a combined rating of 40%–80% or higher even when the cancer is in remission. This guide covers DC 7528 in depth, the Agent Orange presumptive pathway (38 CFR § 3.309(e)), the PACT Act's 2022 expansion, residuals strategy, Permanent & Total disability, and the 2026 monthly pay rates.
VA rates prostate cancer under 38 CFR § 4.115a and § 4.115b, Diagnostic Code 7528 — Malignant Neoplasms of the Genitourinary System. Unlike most conditions where the VA rates on a scale (0%, 10%, 20%, etc.), cancer ratings are fundamentally binary during the active treatment phase: 100% while active, then rate on residuals.
| Condition | Rating | 2026 Pay (Single Vet) |
|---|---|---|
| Active cancer — under treatment (surgery, chemo, radiation, hormone therapy) | 100% | $3,938.58/mo |
| Active local or distant metastases (regardless of treatment status) | 100% | $3,938.58/mo |
| Post-treatment mandatory minimum period | 100% for 6 months after treatment cessation | $3,938.58/mo |
| In remission — no active treatment — rate on residuals | Varies by residual conditions (see below) | Depends on combined residuals rating |
The 100% rating under DC 7528 applies automatically when:
The 6-month post-treatment floor is mandatory under VA regulations. VA cannot reduce your 100% rating below 100% until at least 6 months after treatment has completely ceased. File immediately when diagnosed — your effective date (when back pay begins) is the date you file, not the date of your diagnosis.
Your effective date for VA disability compensation is generally the date you file VA Form 21-526EZ — not the date of diagnosis, not the date you start treatment. If you were diagnosed with prostate cancer in January and don't file until June, you've lost 5 months of back pay at $3,938.58/month ($19,692.90). File as soon as possible after diagnosis — even before treatment begins.
For Vietnam-era veterans, the most important legal provision regarding prostate cancer is 38 CFR § 3.307 and § 3.309(e) — the Agent Orange presumptive regulations under 38 USC § 1116. Prostate cancer is a VA-recognized Agent Orange presumptive condition. Veterans who served in qualifying locations do not need to prove that Agent Orange caused their prostate cancer. VA presumes causation based solely on:
| Location | Dates of Service | Authority |
|---|---|---|
| Republic of Vietnam (including offshore vessels entering inland waters) | January 9, 1962 – May 7, 1975 | 38 CFR § 3.307(a)(6) |
| Korean DMZ (areas near the DMZ) | September 1, 1967 – August 31, 1971 | 38 CFR § 3.307(a)(6)(iv) |
| Blue Water Navy — ships in territorial waters of RVN (12 nautical miles) | January 9, 1962 – May 7, 1975 | Blue Water Navy Act 2019 |
| Thailand — bases with AO storage/spraying | Specific dates per base | VA's AO Exposure and Thailand |
| Johnston Atoll | During AO storage/testing operations | 38 CFR § 3.307(a)(6)(iii) |
| Additional locations expanded by PACT Act (2022) | Varies by location | PACT Act § 3101 |
For Agent Orange presumptive claims, the documentation requirement is straightforward: you need evidence of (1) service in a qualifying location (typically from your DD-214 or military service records) and (2) a current diagnosis of prostate cancer confirmed by a physician. You do not need a nexus letter, a C&P examiner's medical opinion, or evidence of specific herbicide exposure on specific dates.
The Blue Water Navy Vietnam Veterans Act of 2019 extended Agent Orange presumptive eligibility to Navy veterans who served in the territorial sea of the Republic of Vietnam (within 12 nautical miles of the shore) between January 9, 1962 and May 7, 1975. If you were previously denied because your service was "offshore," you may now have a valid presumptive claim. File a Supplemental Claim with evidence of your ship's location in RVN territorial waters.
The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022 significantly expanded VA's service connection rules in ways that affect prostate cancer claims. Key PACT Act provisions relevant to prostate cancer:
The PACT Act added numerous overseas locations to the list of qualifying Agent Orange exposure sites, including additional airfields and bases in the Philippines, Guam, American Samoa, Johnston Atoll, and other locations. Veterans who served at these newly added locations and have prostate cancer now qualify for the Agent Orange presumptive — even if previously denied under the old location list. If you were denied before August 2022 based on service location, file a new Supplemental Claim citing the PACT Act's expanded locations list.
While prostate cancer is not on the PACT Act's initial "presumptive cancer" list for burn pit/airborne hazard exposure, the PACT Act created new pathways for veterans with certain service locations to establish service connection for conditions — including cancers — linked to burn pit smoke and other toxic exposures. Post-9/11 veterans who served in Southwest Asia (Iraq, Afghanistan, Kuwait, Djibouti, etc.) who develop prostate cancer should consult a VA attorney or accredited VSO about whether a burn pit-linked toxic exposure claim is viable, particularly given expanding VA regulations in this area.
Veterans who served at Marine Corps Base Camp Lejeune or MCAS New River, North Carolina, for at least 30 days between August 1, 1953 and December 31, 1987 may have been exposed to contaminated water supply — including known carcinogens trichloroethylene (TCE) and perchloroethylene (PCE). The PACT Act and prior legislation (Camp Lejeune Justice Act 2022) established presumptive service connection for several cancers for Camp Lejeune veterans, including bladder cancer and kidney cancer — but VA's Camp Lejeune cancer list continues to evolve. Veterans who served at Camp Lejeune during the contamination period and have prostate cancer should file a claim and consult with a VA attorney about Camp Lejeune-specific pathways.
Need help with your prostate cancer VA claim?
Free claim review. No upfront cost. VA-accredited attorneys who specialize in cancer claims.
Get Free Claim Help →This is where most veterans leave the most money on the table. When prostate cancer goes into remission and the 100% treatment rating phases out (after the mandatory 6-month post-treatment period), VA re-evaluates based on residuals — the lasting conditions caused by the cancer itself or its treatment (prostatectomy, radiation, hormone therapy). Each residual is rated separately and combined with the others to produce a new combined rating.
Veterans who document their residuals thoroughly before the post-treatment re-evaluation exam frequently maintain combined ratings of 60%–80% or higher even with cancer in remission. Veterans who fail to document residuals often drop to 0% or 10% — a catastrophic financial difference.
Erectile dysfunction is the most common residual of prostatectomy and radiation therapy. VA rates erectile dysfunction at 0% under DC 7522 — but this is not nothing. A 0% service-connected condition for erectile dysfunction opens the door to Special Monthly Compensation at the SMC-K level.
Urinary incontinence — stress incontinence, urge incontinence, or post-void dribbling — is extremely common after prostatectomy and radiation. VA rates urinary incontinence under DC 7542 (Urinary incontinence) based on the degree of impairment:
| Symptom Level | Rating |
|---|---|
| Daytime and nighttime urinary leakage — requiring use of an absorbent device | 40% |
| Involuntary bladder activity — some degree of control, daytime or nighttime leakage | 20% |
| Stress incontinence — leakage with physical activity, no nighttime leakage | 10% |
Document severity honestly and completely. At C&P exams, bring a pad usage diary (if you use pads), describe how incontinence affects your daily activities, and bring records from your urologist documenting severity and treatment (pelvic floor therapy, medications, procedures).
Radiation therapy commonly causes urinary frequency, urgency, and incomplete bladder emptying (urinary retention). These are rated separately from incontinence under DC 7517 (Urethra, stricture) or DC 7518 (Bladder, dysfunction of), depending on the nature of the condition. Veterans with both urinary incontinence and frequency/obstruction should claim both separately — they are distinct ratable conditions that contribute to the combined rating.
Radiation proctitis — inflammation of the rectal tissue from prostate radiation — causes bowel urgency, frequency, rectal bleeding, and incontinence. VA rates bowel dysfunction under DC 7319 (Irritable colon syndrome) or DC 7332 (Rectum, impairment of sphincter control):
A prostate cancer diagnosis — and the ongoing uncertainty about recurrence, the physical effects of treatment, and changes to sexual and urinary function — commonly causes clinically significant depression and anxiety. These are separately ratable conditions when secondary to service-connected prostate cancer.
Androgen deprivation therapy (ADT) — hormone therapy used for prostate cancer — causes testosterone deficiency with significant secondary effects: fatigue, loss of libido (separate from ED), osteoporosis, anemia, and metabolic changes. These can independently support additional service-connected claims. Veterans on long-term ADT should discuss with their oncologist which secondary conditions qualify for separate VA claims and document them thoroughly.
A Vietnam veteran with prostate cancer in remission files secondary claims and ends up with: ED (0% + SMC-K $131.74/mo) + urinary incontinence (40%) + bowel dysfunction/radiation proctitis (20%) + depression secondary to cancer (30%). Combined rating: approximately 70–80% combined. Monthly compensation: $1,716.28–$2,135.04 (single veteran, 2026 rates) + $131.74 SMC-K = $1,848–$2,267/month. This is a dramatically better outcome than accepting a 0% after remission — and every one of these conditions is legitimately ratable.
Your C&P exam will typically occur in two distinct stages:
The initial C&P exam during active treatment is straightforward — the examiner confirms you are receiving active treatment (surgery, chemotherapy, radiation, hormone therapy) and documents it. Bring your oncologist's treatment records, pathology report, and a written treatment plan. The examiner will rate you at 100% for the duration of treatment.
Approximately 6 months after treatment cessation, VA schedules a re-evaluation exam. This is the exam that determines your long-term compensation level. Prepare extensively:
Permanent & Total (P&T) designation is the most favorable VA status for long-term benefit stability. P&T means your conditions are at 100% combined AND are unlikely to improve — preventing future rating reductions and unlocking significant additional benefits.
Benefits of P&T status include:
For prostate cancer veterans, P&T status is most commonly achieved when: (1) Cancer has metastasized and is unlikely to resolve — P&T is typically granted during active metastatic disease, or (2) Secondary residual conditions (ED + incontinence + bowel + depression, combined to 100%) are permanent in nature with no reasonable prospect of improvement
A 100% rating means your combined disability is rated at 100%. P&T is an additional designation that your conditions are permanent. You can be at 100% without being P&T — meaning VA could later reduce your rating if they believe improvement occurred. Seek P&T designation by documenting the permanence of your secondary conditions with your treating physicians. A letter from your urologist stating that your urinary incontinence is unlikely to improve significantly is powerful supporting evidence for a P&T request.
| Rating | Single Veteran | With Spouse | With Spouse + 1 Child |
|---|---|---|---|
| 100% (active treatment / metastatic) | $3,938.58/mo | $4,167.15/mo | $4,294.10/mo |
| 80% (residuals combined) | $2,135.04/mo | $2,322.05/mo | $2,422.05/mo |
| 70% (residuals combined) | $1,716.28/mo | $1,878.21/mo | $1,966.21/mo |
| 60% (residuals combined) | $1,361.88/mo | $1,497.39/mo | $1,572.39/mo |
| 50% (residuals combined) | $1,075.16/mo | $1,214.03/mo | $1,282.03/mo |
| 40% (residuals combined) | $758.28/mo | $869.96/mo | $921.96/mo |
| 30% (residuals combined) | $508.05/mo | $569.74/mo | $617.74/mo |
| 0% with SMC-K (ED only) | $131.74/mo additional | $131.74/mo additional | $131.74/mo additional |
All VA disability compensation is federal income tax exempt (26 U.S.C. § 104) and exempt from state income tax in most states. These amounts are in addition to any military retirement pay, Social Security, or private pension you receive.
This usually means VA did not recognize your Agent Orange eligibility — often because of incomplete DD-214 documentation of Vietnam service or because you served as Blue Water Navy (prior to the 2019 act) or at a location not previously on the qualifying list. Solution: File a Supplemental Claim with your complete DD-214, ship logs showing entry into RVN territorial waters (for Blue Water Navy), or evidence of service at the newly-recognized PACT Act locations. A VSO or VA attorney can help gather the correct documentation.
This is the most common denial after the 100% treatment period ends. VA may reduce your rating to 0% without properly evaluating secondary conditions. Response: File a Supplemental Claim immediately with medical evidence documenting each residual condition (urologist records for ED/incontinence, gastroenterology records for bowel issues, mental health records for depression). If you have not separately filed for secondary conditions, do so now.
Request a copy of the C&P exam report (it's your right under 38 CFR § 3.159). If the examiner's opinion was inadequate — failed to address all secondary conditions, used conclusory language without rationale, or appears incomplete — file a Higher-Level Review requesting a different examiner, or file a Supplemental Claim with a private nexus letter from your treating physician that rebutts the inadequate exam.
At 2026 rates: single veteran at 100% — $3,938.58/month ($47,263/year). With a spouse: $4,167.15/month. With a spouse and one child: $4,294.10/month. This rate applies during active treatment and for 6 months after treatment ends. All VA compensation is federal income tax-exempt.
Yes — VA is required by regulation to reduce the 100% cancer rating after the 6-month post-treatment minimum period, unless the cancer has metastasized or is otherwise still active. The reduction is based on residual conditions. The key is documenting all secondary conditions thoroughly before the re-evaluation exam. Veterans with significant residuals frequently maintain 60%–80%+ combined ratings in remission.
Yes. ED is rated at 0% under DC 7522, but the 0% service connection unlocks SMC-K at $131.74/month (2026) in additional tax-free compensation. You must separately file for ED as secondary to service-connected prostate cancer — VA will not automatically rate it.
Yes. P&T is typically granted during active metastatic cancer, or when secondary residual conditions combined to 100% are documented as permanent. P&T unlocks CHAMPVA for dependents, protects against future rating reductions, and unlocks property tax exemptions in most states.
The PACT Act expanded the list of qualifying Agent Orange exposure locations — meaning some veterans who were previously denied due to service location may now qualify for the prostate cancer presumptive. If you were denied before August 2022 based on service location, file a Supplemental Claim citing the PACT Act's expanded qualifying locations list (check the VA's current PACT Act presumptive locations).
Editorial Standards: This article was written by Marcus J. Webb, a veterans benefits researcher specializing in 38 CFR Part 4, DC 7528, and cancer-related VA disability ratings. Verified against 38 CFR § 4.115a/§ 4.115b, 38 CFR § 3.309(e), and VA.gov guidance. Last reviewed: June 2026. Not legal advice.
VA cancer claims — especially secondary conditions after remission — are complex. An accredited VA attorney can help maximize your rating and appeal denials. They only get paid if you win. claim.vet connects veterans with pre-screened attorneys at no cost.
Find a VA Attorney → Free Case Score